An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677313PMC
http://dx.doi.org/10.1038/s41598-020-77427-xDOI Listing

Publication Analysis

Top Keywords

publisher correction
4
correction genome-wide
4
genome-wide structure-based
4
structure-based survey
4
survey nucleotide
4
nucleotide binding
4
binding proteins
4
proteins tuberculosis
4
tuberculosis amendment
4
amendment paper
4

Similar Publications

Purpose: To utilize optical coherence tomography (OCT) and SS-OCT angiography (SS-OCTA) for quantifying morphological changes seen in eyes with recalcitrant neovascular age-related macular degeneration (nAMD) transitioned to intravitreal faricimab injections during the manufacturer's recommended induction phase of treatment.

Methods: Fifty-four treatment-recalcitrant patients (60 eyes) were recruited. OCT and SS-OCTA images were obtained at 0 and 3 months.

View Article and Find Full Text PDF

How to correct QT interval after cardiac resynchronisation therapy.

J Electrocardiol

January 2025

Victorian Heart Institute, Monash University, Clayton, VIC, Australia; Victorian Heart Hospital, Clayton, VIC, Australia. Electronic address:

Introduction: This study evaluates various formulae used to correct the QT interval in patients with wide QRS complexes to calculate corrected QT (QTc) following Cardiac Resynchronisation Therapy (CRT).

Methods: We included patients with severe heart failure and left bundle branch block, presenting with a QRS duration of at least 120 milliseconds, who underwent successful CRT implantation. Patients were excluded if they had non-lateral left ventricular lead placement, metabolic disorders, atrial fibrillation, atrial tachycardia, or high-degree atrioventricular block prior to implantation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!